Biopharmaceutical benchmarks

被引：78

作者：

Walsh, G ^{[1
]}

机构：

[1] Univ Limerick, Ind Biochem Programme, Limerick, Ireland

来源：

NATURE BIOTECHNOLOGY | 2000年 / 18卷 / 08期

关键词：

D O I：

10.1038/78720

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline.

引用

页码：831 / 833

页数：3

共 8 条

[1] Proteomics: quantitative and physical mapping of cellular proteins [J].

Blackstock, WP ;

Weir, MP .

TRENDS IN BIOTECHNOLOGY, 1999, 17 (03) :121-127

[2] Dolly, Polly and other 'ollys': likely impact of cloning technology on biomedical uses of livestock [J].

Colman, A .

GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING, 1999, 15 (3-5) :167-173

[3] Functional genomics: from genes to new therapies [J].

Dyer, MR ;

Cohen, D ;

Herrling, PL .

DRUG DISCOVERY TODAY, 1999, 4 (03) :109-114

[4]

ROHRICHT P, 1999, BIOPHARM SEP, P52

[5]

ROHRICHT P, 1999, BIOPHARM MAR, P46

[6]

WALSH G, 1998, BIOPHARMACEUTICALS B

[7] Proteomics in drug discovery [J].

Wang, JH ;

Hewick, RM .

DRUG DISCOVERY TODAY, 1999, 4 (03) :129-133

[8] Knowledge discovery in gene-expression-microarray data: mining the information output of the genome [J].

Zweiger, G .

TRENDS IN BIOTECHNOLOGY, 1999, 17 (11) :429-436

← 1 →